Köhrle Josef
Institut für Experimentelle Endokrinologie, Charité Campus Virchow-Klinikum (CVK), Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Eur Thyroid J. 2019 Jun;8(3):115-129. doi: 10.1159/000497141. Epub 2019 May 21.
Since the discovery of L-thyroxine, the main secretory product of the thyroid gland, and its major metabolite T3, which exerts the majority of thyroid hormone action via ligand-dependent modulation of the function of T3 receptors in nuclei, mitochondria, and other subcellular compartments, various other T4-derived endogenous metabolites have been identified in blood and tissues of humans, animals, and early protochordates. This review addresses major historical milestones and experimental findings resulting in the discovery of the key enzymes of thyroid hormone metabolism, the three selenoprotein deiodinases, as well as the decarboxylases and amine oxidases involved in formation and degradation of recently identified endogenous thyroid hormone metabolites, i.e. 3-iodothyronamine and 3-thyroacetic acid. The concerted action of deiodinases 2 and 3 in regulation of local T3 availability is discussed. Special attention is given to the role of the thyromimetic "hot" metabolite 3,5-T2 and the "cool" 3-iodothyronamine, especially after administration of pharmacological doses of these endogenous thyroid hormone metabolites in various animal experimental models. In addition, available information on the biological roles of the two major acetic acid derivatives of thyroid hormones, i.e. Tetrac and Triac, as well as sulfated metabolites of thyroid hormones is reviewed. This review addresses the consequences of the existence of this broad spectrum of endogenous thyroid hormone metabolites, the "thyronome," beyond the classical thyroid hormone profile comprising T4, T3, and rT3 for appropriate analytical coverage and clinical diagnostics using mass spectrometry versus immunoassays for determination of total and free concentrations of thyroid hormone metabolites in blood and tissues.
自从发现甲状腺的主要分泌产物L-甲状腺素及其主要代谢产物T3以来,T3通过对细胞核、线粒体及其他亚细胞区室中T3受体功能的配体依赖性调节发挥大部分甲状腺激素作用。在人类、动物和早期原索动物的血液和组织中,还鉴定出了多种其他源自T4的内源性代谢产物。本综述阐述了甲状腺激素代谢关键酶(三种硒蛋白脱碘酶)以及参与最近鉴定出的内源性甲状腺激素代谢产物(即3-碘甲腺原氨酸和3-甲状腺乙酸)形成与降解的脱羧酶和胺氧化酶的发现过程中的主要历史里程碑和实验结果。讨论了脱碘酶2和3在调节局部T3可用性方面的协同作用。特别关注了拟甲状腺“热”代谢产物3,5-T2和“冷”3-碘甲腺原氨酸的作用,尤其是在各种动物实验模型中给予这些内源性甲状腺激素代谢产物药理剂量之后。此外,还综述了关于甲状腺激素的两种主要乙酸衍生物(即Tetrac和Triac)以及甲状腺激素硫酸化代谢产物生物学作用的现有信息。本综述探讨了这一广泛的内源性甲状腺激素代谢产物谱(“甲状腺激素组”)的存在所带来的影响,这一谱超出了包括T4、T3和反T3在内的经典甲状腺激素谱,对于使用质谱法与免疫测定法进行血液和组织中甲状腺激素代谢产物总浓度和游离浓度的测定以实现适当的分析覆盖范围和临床诊断具有重要意义。